2012-22784. Draft Guidance for Industry on Self-Identification of Generic Drug Facilities, Sites, and Organizations; Availability; Correction  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice; correction.

    SUMMARY:

    The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of Monday, August 27, 2012 (77 FR 51811). The document announced a draft guidance for industry entitled “Self-Identification of Generic Drug Facilities, Sites, and Organizations.” The document was published with an incorrect docket Start Printed Page 57095number. This document corrects that error.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Joyce Strong, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave. Bldg. 32, Rm. 3208, Silver Spring, MD 20993-0002, 301-796-9148.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In FR Doc. 2012-20946, appearing on page 51811 in the Federal Register of Monday, August 27, 2012, the following correction is made:

    1. On page 51811, in the third column, the docket number is corrected to read “FDA-2012-D-0881”.

    Start Signature

    Dated: August 30, 2012.

    Leslie Kux,

    Assistant Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2012-22784 Filed 9-14-12; 8:45 am]

    BILLING CODE 4160-01-P

Document Information

Comments Received:
0 Comments
Published:
09/17/2012
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice; correction.
Document Number:
2012-22784
Pages:
57094-57095 (2 pages)
Docket Numbers:
Docket No. FDA-2012-D-0881
PDF File:
2012-22784.pdf